IgA nephropathy associated with hepatitis B virus antigenemia

Area of Science:

• Nephrology
• Hepatology
• Immunology

Background:

• IgA nephropathy (IgAN) is a common cause of glomerulonephritis.
• The role of persistent hepatitis B virus (HBV) infection in IgAN pathogenesis is not fully understood.
• HBV antigenemia is common in certain populations, but its direct link to kidney disease requires further investigation.

Purpose of the Study:

• To investigate the pathogenetic role of hepatitis B virus (HBV) antigenemia in inducing IgA nephropathy (IgAN).
• To examine the presence of HBV antigens within renal tissue of patients with concurrent IgAN and HBV infection.

Main Methods:

• Study included 10 patients diagnosed with IgA nephropathy and HBV antigenemia.
• Patients had no prior liver disease history and normal liver function tests.
• Immunoperoxidase staining was used to detect hepatitis B core antigen (HBcAg) and hepatitis B surface antigen (HBsAg) in kidney biopsies.

Main Results:

• All patients were persistent carriers of HBV, confirmed by positive HBsAg and high-titer anti-HBcAg.
• HBcAg and HBsAg were detected in the nuclei and cytoplasm of glomerular mesangial cells in 8 out of 10 patients.
• No prior liver disease or abnormal liver function tests were noted in the study cohort.

Conclusions:

• These findings suggest that immune complexes involving HBcAg and HBsAg may play a role in inducing IgA nephropathy.
• Persistent HBV infection, even without overt liver disease, could be a contributing factor to IgAN development.
• Further research is warranted to elucidate the precise mechanisms of HBV-induced kidney damage in IgAN.